This review emphasizes that cardiovascular disease in ESRD is driven by accelerated atherogenesis, inflammation, and oxidative stress, suggesting that traditional clinical definitions of CVD may underestimate the true atherosclerotic burden.
Answers are grounded in this paper and cite their sources.
Traditional risk models may underestimate CVD burden in ESRD; leaves open whether targeting inflammation improves outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Stenvinkel et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: